Skip to main content
. 2020 May 11;105(7):e2398–e2407. doi: 10.1210/clinem/dgaa250

Table 4.

Observational and 1-sample MR Associations Between BMI, WHR, and Type 2 Diabetes and Benign Nodular Thyroid Disease and Thyroid Cancer in Men and Women

Characteristic OR Benign Nodular Disease 95% CI P Value OR Thyroid Cancer 95% CI P Value
Female BMI
  Measured 1.18 1.10-1.26 4.2 × 10-6 1.02 0.89-1.18 0.74
  1-sample MR 0.93 0.63-1.38 0.71 0.87 .036-2.09 0.75
Male BMI
  Measured 1.06 0.92-1.21 0.42 1.02 0.82-1.27 0.87
  1-sample MR 0.80 0.34-1.88 0.6 3.13 0.73-13.43 0.12
Female WHR
  Measured 1.14 1.07-1.22 1.2x104 1.05 0.92-1.22 0.46
  1-sample MR 1.45 0.85-2.50 0.17 1.05 0.33-3.30 0.94
Male WHR
  Measured 1.22 1.07-1.40 3.1 × 10-3 1.30 1.05-1.62 1.7 × 10-2
  1-sample MR 1.69 0.50-5.66 0.4 3.67 0.56-24.12 0.18
Female WHR adjusted for BMI
  Measured 1.08 1.01-1.16 2.1 × 10-2 1.04 0.91-1.20 0.57
  1-sample MR 1.00 0.79-1.26 0.97 0.74 0.45-1.20 0.22
Male WHR adjusted for BMI
  Measured 1.20 1.06-1.37 5.6 × 10-3 1.34 1.09-1.67 6.5 × 10-3
  1-sample MR 1.36 0.80-2.29 0.25 1.04 0.46-2.33 0.93

P values calculated using logistic regression adjusted for age, with smoking status, alcohol consumption, Townsend deprivation index, BMI, and T2DM used as covariates for measured values.

adjWHR, WHR adjusted for BMI; BMI, body mass index; CI, confidence interval; HDL, high-density lipoprotein; LDL, low-density lipoprotein; OR, odds ratio; T2DM, type 2 diabetes mellitus. WHR, waist-hip ratio.